Status:
WITHDRAWN
Feasibility and Efficacy of rTMS in Healthy Persons
Lead Sponsor:
Wayne State University
Conditions:
Executive Dysfunction
Pain
Eligibility:
All Genders
21-60 years
Phase:
NA
Brief Summary
Transcranial magnetic stimulation (TMS) is a neuromodulation device that is FDA-approved for use in treating depression and obsessive compulsive disorder. TMS works by applying a safe, electromagnetic...
Detailed Description
The short-term goal of this pilot project is to establish the feasibility and efficacy of repetitive transcranial magnetic stimulation (rTMS) on cognitive, behavioral, and physiological measures in a ...
Eligibility Criteria
Inclusion
- Healthy
- Right handed
- 21-60 years of age
- IQ score greater than 80
- Eligible if using tobacco, alcohol, or marijuana fewer than 3 times per week; each "time" must be less than 3 cigarettes or drinks, or less than 1 marijuana "joint"
Exclusion
- Under influence of any substances during any session
- Use of illicit substances in the past 30 days
- Pregnant
- Medical conditions that prohibit the use of rTMS (e.g. history of seizures or medications that lower seizure threshold)
- Current DSM-5 Axis I psychiatric disorders, or any history of substance use disorders.
Key Trial Info
Start Date :
April 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04074811
Start Date
April 10 2023
End Date
April 10 2023
Last Update
April 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wayne State University
Detroit, Michigan, United States, 48201